Invention Grant
- Patent Title: Substituted aryl sulfone derivatives as calcium channel blockers
- Patent Title (中): 取代的芳基砜衍生物作为钙通道阻断剂
-
Application No.: US12678454Application Date: 2008-09-30
-
Publication No.: US08304434B2Publication Date: 2012-11-06
- Inventor: Prasun K. Chakravarty , Yanbing Ding , Joseph L. Duffy , Hassan Pajouhesh , Pengcheng Patrick Shao , Sriram Tyagarajan , Feng Ye
- Applicant: Prasun K. Chakravarty , Yanbing Ding , Joseph L. Duffy , Hassan Pajouhesh , Pengcheng Patrick Shao , Sriram Tyagarajan , Feng Ye
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Sylvia A. Ayler; Gerard M. Devlin
- International Application: PCT/US2008/011286 WO 20080930
- International Announcement: WO2009/045382 WO 20090409
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D401/12

Abstract:
A series of substituted aryl sulfone derivatives represented by Formula I, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, calcium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, urinary incontinence, itchiness, allergic dermatitis, epilepsy, diabetic neuropathy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, sleep disorder, bipolar disorder and stroke, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds.
Public/Granted literature
- US20100210620A1 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers Public/Granted day:2010-08-19
Information query
IPC分类: